Please provide your email address to receive an email when new articles are posted on . Inpatient vs. outpatient fast-track total knee arthroplasties yielded similar outcomes. Inpatient vs. outpatient ...

The company said that the designation is supported by clinical data which demonstrates a 33% objective response rate for ...

STAFFORD, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, ...

Pelareorep now has Fast Track Designation for two gastrointestinal cancers, solidifying its potential as an immunotherapeutic platform therapy in gastrointestinal cancers ...